Live feed06:30:00·15mPRReleasevia QuantisnowSatellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable Safety Profile in DMD Adults Treated with SAT-3247ByQuantisnow·Wall Street's wire, on your screen.MSLE· Satellos Bioscience Inc.Health Care
